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mastocytosis, and mast cell sarcoma. A 45-year-old woman presented
with pancytopenia and high fever for 3 months. The bone marrow
biopsy was markedly hypercellular with interstitial immature infiltrate,
perivascular and paratrabecular spindled and atypical mast cell infiltrate
(hypogranular with Giemsa stain). The immunohistochemistry showed
30%–40% cells positive for CD34 and CD117 (dim); and 40% mast cells
positive for CD25 and CD117, and negative for CD2. The flow
cytometry revealed a population of myeloblasts (positive for HLA-DR,
CD34, CD117 [dim], and MPO) and a separate aberrant mast cell
population (positive for CD25, bright CD123, and CD117). The
molecular study showed the presence of KIT D816V mutation,
confirming the diagnosis of systemic mastocytosis with an associated
hematologic neoplasm (SM-AHN), which was acute myeloid leukemia
in this case. SM-AHN is a rare entity that requires fulfillment of criteria
for systemic mastocytosis and associated hematologic neoplasm for its
diagnosis. As per the literature, chronic myelomonocytic leukemia is the
most common associated neoplasm with this entity, though in our case
the associated neoplasm was acute myeloid leukemia. This entity poses
diagnostic challenges and is associated with high-risk disease. With the
limited data, splenomegaly, elevated alkaline phosphatase, and
mutations in SRSF2/ASXL1/RUNX1 are considered as adverse prognostic markers in patients with systemic mastocytosis. We recommend that
correlation of different techniques should be used for the proper
diagnosis and characterization of the disease. This rare entity should be
reported to clearly define its pathogenesis and prognostic implications.

A Pediatric Case of Erdheim-Chester Disease
(Poster No. 127)
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Karen Galvis Castro, MD (karen.galvis@fsfb.org.co); Martha
Romero, MD, PhD; Lucy Higuera, MD; Rafael Andrade, MD; Carlos
Saavedra, MD. Department of Pathology and Laboratories, Hospital
Universitario Fundación Santa Fé de Bogotá, Bogota, D.C., Colombia.
Erdheim-Chester disease (ECD) is a rare, systemic form of non–
Langerhans cell histiocytosis of unknown etiology. It primarily affects
adults, but rare pediatric cases have also been diagnosed. Virtually any
organ or tissue can be infiltrated by ECD and some patients may not
have typical bilateral and symmetric involvement of long bones.
Mutation of BRAF V600E has been found in more than 50% of cases
and it can be detected by immunohistochemistry. We report a case of a
9-year-old boy with a clinical history of Langerhans cell histiocytosis
(LCH). He presented an infiltrative lesion in the frontoparietal region
with skull and bilateral orbit involvement. Histology showed diffuse
infiltration by histiocytes, some with single small nuclei and foamy
cytoplasm, and others with eosinophilic cytoplasm. A few Touton-like
giant cells were observed, and fibrosis and lymphocytes were also
present (Figure 2.127). On immunohistochemistry studies, the histiocytes were positive for CD68, CD163, and BRAF protein, and negative
for CD1a, S100, CD21, and CD23. BRAF V600F mutation testing was
positive. With these findings, the diagnosis of pediatric ECD was
suggested. Recently a classification system has been proposed, with
EDC and LCH included in the L group. Both diseases share common
properties and overlap can occur in up to 12% of ECD cases. This
association was presented in this case. The rarity of the disease can
make the diagnosis challenging. Therefore, a multidisciplinary approach

with radiologic and histopathologic criteria is required. Furthermore,
the presence, of BRAF mutation can be useful to confirm difficult cases.

Chronic Myelocytic Leukemia With Erythro-leukemic Blast
Crisis
(Poster No. 128)
Sarah Glogowski, DO (sarah.glogowski@gmail.com); John Krause,
MD; Junlin Zhang, MD. Department of Pathology, Baylor University
Medical Center, Baylor Scott & White Health, Dallas, Texas.
Here we report the case of a 56-year-old man who presented to his
primary care office with rapid onset symptoms of dorsalgia with lower
extremity paresthesia, weight loss, fevers, chills, and night sweats.
Magnetic resonance imaging incidentally identified diffuse abnormal
marrow signal throughout the lumbar spine and additional areas of soft
tissue densities within the epidural spaces. CT of the chest, abdomen,
and pelvis identified splenomegaly and scattered lytic bone lesions. The
peripheral blood smear revealed a leukocytosis with a left shift and
occasional blasts. Flow cytometry, on whole blood, revealed a
granulocytic left shift with 0.5% circulating blasts. These results
prompted a bone marrow biopsy to be performed, which demonstrated
hypercellularity (95%), with increased erythroblasts, myeloblasts, and
mild erythroid dyspoiesis. Immunohistochemistry for CD71 identified a
significant erythroid population in the marrow as well as a prominent
CD34þ myeloblast population. Flow cytometry performed on the bone
marrow detected 33.9% large myeloblast population. Bone marrow
cytogenetic analysis revealed a complex karyotype. BCR/ABL1 fluorescence in situ hybridization was positive for gene rearrangements.
Molecular studies, performed on whole blood, revealed a t(9:22) BCRABL1 major p210 fusion. This is an unusual case because the peripheral
blood initially favored an erythroid leukemia morphologically; however,
upon additional testing, the BRL/ABL1 translocation was discovered,
revealing the origin of erythroid leukemia to be from chronic myelocytic
leukemia. Chronic myelocytic leukemia with erythroid crisis is a rare
entity with only a few reported cases of transformation of underlying
chronic myelocytic leukemia to acute erythroid leukemia.

Cost Analysis of Orchiectomy Specimens From Patients
With Gender Dysphoria
(Poster No. 129)
Christopher Jurief, DO (cjurief@kumc.edu); Ameer Hamza, MD.
Department of Pathology and Laboratory Medicine, University of
Kansas Medical Center, Kansas City.
Context: Hormonal therapy followed by orchiectomy is an integral
part of management of gender dysphoria. The orchiectomy specimens
from these patients are routinely subjected to histopathologic evaluation. The histopathologic findings are usually hormonal therapy related
and are consistent and uniform. We intended to perform a cost analysis
of these specimens.
Design: Orchiectomy specimens from patients with gender dysphoria received at our institution from February 2019 to February 2021 were
included in the study. Data including patient age, weight of the testicles,
number of tissue sections, processing cost, and histologic findings were
collected.
Results: A total of 66 specimens were identified. Mean age of the
patients was 35.9 6 14.2 years. Mean weight of the testes were 28.1 6
8.8 g (right) and 27.8 6 9.4 g (left). Histologic evaluation showed
hyalinization around seminiferous tubules and diminished/absent
spermatogenesis in most cases. No tumor or unexpected findings were
identified in any case. Mean number of tissue sections submitted per
case was 5.7 6 1.2. The estimated cost of processing, including
technician labor, was $41.75 per specimen.
Conclusions: Orchiectomy specimens from patients with gender
dysphoria almost always demonstrate hormonal therapy effect and
chances of discovering any incidental finding of clinical significance are
negligible. Diligent gross inspection and minimal tissue sampling with
additional sampling reserved for gross abnormality can adequately
document the histologic findings in a cost-effective manner.

How Much Time Do General Surgical Pathologists Spend
on Diagnostic Data Entry?
(Poster No. 130)
Zhenhong Qu, MD, PhD1 (zqu@oakland.edu); Lanjing Zhang,
MD2; Xianzhong Ding, MD, PhD3; Kausar Jabbar, MD.1 1Department of
Pathology, William Beaumont Hospital, Troy, Michigan; 2Department
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of Pathology, Princeton Medical Center, Plainsboro, New Jersey;
3
Department of Pathology, Loyola University Medical Center, Maywood, Illinois.
Context: As many pathology institutions have eliminated transcription service by office assistants, pathologists assume the task of
diagnostic data entry (DDE) into pathology reports in the laboratory
information system. This is not a trivial undertaking, yet tangible data
are lacking on how much DDE adds to the workload of pathologists.
Without such data, it is very difficult to assess the financial benefit of
such a task shift and establish benchmarks.
Design: Four practicing pathologists covering a general surgical
pathology service in 3 institutions with different laboratory information
systems were selected for their dominant DDE method (speech
recognition, pre-text, or manual typing) to generate greater than twothirds of their pathology reports. In each sign-out session, the starting
and ending times of the session were recorded. An online stopwatch
was used to collate the DDE time for each surgical case during the
session. Time for other activities, such as case information retrieval,
slide review, and filling out a synoptic report, was not counted.
Results: Time for DDE, out of a total of 156 hours of consecutive
sign-out sessions, was recorded. Judging by the ratio of ‘‘slides/
specimen part/case,’’ the specimen-type mix appears typical of the
general pathology service of a tertiary health care center. The results
summarized in the Table demonstrate that pathologists spent .24.8%
of sign-out time for DDE (median, 28.5%; quartile, 25.7%–29.5%).
Conclusions: With about 28.5% sign-out time devoted to DDE, the
established workload of pathologists should be recalibrated. Since 1
full-time transcriptionist can cover DDE for 4–5 pathologists, the
financial benefit of shifting DDE to pathologists should be reassessed.

pathogenesis of lymphocytic colitis is not well understood, and
although a possible role of pathogenic microorganisms has been
proposed, there are no reports on simultaneous spirochetosis and
lymphocytic colitis in a single patient in the English literature. When
managing patients with neoplasm history, ‘‘nonmalignant’’ findings
should not be missed or omitted in order to solve the puzzle and to
optimize patient care. An 80-year-old man with heavy-chain c
globinemia not requiring systemic therapy reported several months of
diarrhea with intermittent abdominal cramping refractory to lifestyle
changes. Clinically enterocolonic amyloidosis was suspected and a
colonoscopy was performed. The colonoscopy was unremarkable;
hence random biopsies were obtained. Microscopic examination
identified architecturally intact colonic mucosa with diffuse regeneration, intraepithelial lymphocytosis, and peculiar ‘‘false brush border,’’
and goblet cell–sparing basophilic epithelial fringe. Findings suggest
coexisting lymphocytic colitis and spirochetosis (Figure 2.131, A and B).
Subsequent immunohistochemistry (Figure 2.131, C) and special stains
(Figure 2.131, D) confirmed both entities and excluded the hypothesis
of amyloidosis. The patient was managed accordingly, with quick
resolution of his symptoms. This unique case highlights a new
codiagnosis in the setting of chronic diarrhea with no endoscopic
mucosal lesion. It could be easily missed, particularly in patients with
neoplasm history, which could cause delays in diagnoses and treatment.
This report highlights the impact of timely recognition of rare diseases
in ensuring proper patient management.

Summary of DDE Time by Pathologists
Pathologist

Speech recognition
Pre-texted
Pre-texted
Manual typing

Total
DDE Time,
Time, h Mean, %
68.82
31.51
48.50
7.20
156.03

24.83
28.78
29.74
28.29
29.07

SD
5.65
5.81
5.40
6.98
5.77
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Intriguing Simultaneous Intestinal Spirochetosis and
Lymphocytic Colitis in an 80-Year-Old Man With HeavyChain Gamma Globinemia
(Poster No. 131)
Daniela Pereira, MD1 (danielavpereira@gmail.com); Kun Jiang,
MD, PhD.2 1Department of Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal; 2Department of
Pathology, Moffitt Cancer Center, Tampa, Florida.
Intestinal spirochetosis and lymphocytic colitis are both rare clinical
encounters in patients diagnosed with neoplastic diseases. The

Optimizing Fluorescence In Situ Hybridization Test Utilization in Unsorted and CD138-Enriched Samples of Plasma Cell
Myeloma at Diagnosis Versus Persistent/Relapsed Disease
(Poster No. 132)
Priyatharsini Nirmalanantham, MD (Priyatharsini.Nirmalanantham@UHhospitals.org); Howard Meyerson, MD; Ehsan Malek, MD;
Shashirekha Shetty, PhD. Department of Pathology, Case Western Reserve University/University Hospitals, Cleveland, Ohio.
Context: Fluorescence in situ hybridization (FISH) testing on enriched CD138þ plasma cells assists in identifying genetic abnormalities for risk
stratification in multiple myeloma. Limited specimens are often encountered, precluding evaluation using all the desired probes. Therefore, to
optimize test utilization, we assessed FISH detection rates among unsorted and CD138-enriched samples.
Design: A total of 439 patients with a plasma cell neoplasm (257 unsorted, 182 CD138-enriched) were examined by FISH for abnormalities of 3, 7,
11, TP53, 1q21(CKS1B), and IGH. IGH rearrangement triggered reflex testing for t(4;14) and t(14;16), and t(11;14). Differences between enriched and
unsorted cases at diagnosis and persistent and relapse (P/R) disease were assessed.
Results: Overall, abnormalities were detected more often in enriched versus unsorted samples for 1q21 (46/137 versus 36/183, P ¼ .005),
hyperdiploidy (46/137 versus 36/183, P ¼ .005), and IGH (36/137 versus 22/183, P ¼ .001), although no differences were seen in detection of TP53
aberrations. At diagnosis, 1q21 and IGH rearrangement abnormalities were detected more frequently in enriched samples (P ¼ .03 and .01,
respectively) (Table), whereas no difference in detection rate was noted in P/R samples with any of the probes (Table). The frequency of t(11;14),
t(4;14), and t(14;16) upon reflex testing at diagnosis was 46%, 16%, and 6%, respectively, versus 33%, 11%, and 11% in P/R disease.
Conclusions: Difference in the detection of FISH abnormalities between unsorted and enriched specimens is dependent on disease state and
probe type. We therefore propose a 2-tier testing algorithm for enriched samples with IGH and CKS1B testing at diagnosis and IGH, CKS1B, and TP53
assessment for P/R disease.
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